Skip to content

Studying the effect of pentoxifylline administration on the treatment of children with sepsis

Studying the effect of pentoxifylline administration on the prognosis of children with community-acquired sepsis.

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20190522043672N6
Enrollment
36
Registered
2025-07-12
Start date
2025-07-22
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

community acquired sepsis. Other sepsis

Interventions

Intervention 1: Intervention group: Patients in this group receive a suspension prepared from a 400 mg pentoxifylline tablet (the tablet is crushed at the time of administration and suspended in water

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Months to 10 Years

Inclusion criteria

Inclusion criteria: A child with sepsis is admitted to the intensive care unit of Akbar Children's Hospital in Mashhad. Meets at least two of the criteria for systemic inflammatory response syndrome Age between 1month and 10 years

Exclusion criteria

Exclusion criteria: children with adrenal insufficiency lack of parental consent for the child s continued participation in the study Those who are known to be intolerant to Methylxanthines and Pentoxifylline

Design outcomes

Primary

MeasureTime frame
Heart rate. Timepoint: Daily examinations by an intensive care specialist continue for one week before the intervention begins. Method of measurement: Monitoring Device.;Respiratory rate. Timepoint: Daily examinations by an intensive care specialist continue for one week before the intervention begins. Method of measurement: Monitoring Device.;Blood oxygen saturation. Timepoint: Daily examinations by an intensive care specialist continue for one week before the intervention begins. Method of measurement: Pulse Oximetry.;Blood Pressure. Timepoint: Daily examinations by an intensive care specialist continue for one week before the intervention begins. Method of measurement: Monitoring Device.

Secondary

MeasureTime frame
Length of stay in the intensive care unit. Timepoint: Daily check-ups by the intensive care physician continue for one week before the intervention. Method of measurement: Researcher-made questionnaire.;Need for a ventilator. Timepoint: Daily checks by an intensive care physician continue for one week before the intervention begins. Method of measurement: Temporarily or permanently unable to breathe independently.;Need for a vasopressor. Timepoint: Daily checks by an intensive care physician continue for one week before the intervention begins. Method of measurement: Monitoring device.;Mortality. Timepoint: Daily examinations by an intensive care physician continue for one week from the start of the intervention. Method of measurement: Monitoring device.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMajid Sezavar

Mashhad University of Medical Sciences

sezavardm@mums.ac.ir+98 51 3870 9225

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026